Skip to main content

ECHA lists substances for evaluation

27th March 2019

Submitted by:

Andrew Warmington

At its annual forum for exchange of information on enforcement in Helsinki on 19-22 March, the European Chemicals Agency (ECHA) adopted the updated Community rolling action plan (CoRAP) for substance evaluation. This now lists 100 substances, 24 of them newly allocated, which are to be evaluated under REACH by 19 EU member states in the years 2019-2021.

For the 31 specified for this year, the evaluating authorities will have 12 months – to 19 March 2020 - to carry their work out. Because of this decision and a change since the start of the year to address its evaluation decisions to all registrants with non-compliant dossiers, rather than just lead registrants, ECHA subsequently invited enforcement authorities to prioritise the enforcement of evaluation decisions.

The stated aim of evaluation is “to clarify whether further information is needed to conclude whether a substance poses a risk to people or the environment”. If so, registrants will be asked to provide this information, which is why they are encouraged to coordinate their actions and contact the evaluating member state, and also urged to update their dossiers, especially for uses and exposures. The authorities will assess any concerns and, where relevant, initiate regulatory risk management actions.

Substances are selected for evaluation based on concerns about suspected serious hazard properties. They may be sensitisers, persistent, bioaccumulative and toxic (PBT), carcinogenic, mutagenic and reprotoxic (CMR) or endocrine disruptors. Wide dispersive worker or consumer use is also considered.

Among other changes, evaluation was brought forward for two substances: triclocarban and bis(4-chlorophenyl) sulphone. For the remaining cases, the evaluation year was postponed to wait for the results on ongoing dossier evaluation processes on these or similar substances, due to limited member state resources or, in 11 cases, because the member state requested their withdrawal for various reasons.

Full details of the substances affected are listed on the ECHA website. The agency added that it plans to evaluate 44 and 25 substances in 2020 and 2012 respectively, though this may be changed when the CoRaP is next updated in March 2020.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington